Author

Ja-Lok Ku

Seoul National University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Andrew J. AguirreiD· 1 shared Eun Hee JungiD· 1 shared Eunjung Alice LeeiD· 1 shared Haeseong ParkiD· 1 shared Heejung ChaeiD· 1 shared Jee Hyun KimiD· 1 shared Jeongmin SeoiD· 1 shared Ji Won ParkiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew J. AguirreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation

Sung‐Hyun Hwang, Mingyun Bae, Ji‐Won Kim, Seung Yoon Hyun, Kui‐Jin Kim, Joshua H. Choe, Min Jung Kim, Ji Won Park, Seung‐Yong Jeong, Songji Choi, Woochan Park, Jeongmin Seo, Heejung Chae, Min-Su Kang, Eun Hee Jung, , Keun‐Wook Lee

This paper identifies VEGFA-VEGFR2 signaling driven by PI3Kγ activation as a mechanism of acquired resistance to KRAS G12D inhibitors and shows that blocking this pathway restores drug sensitivity in resistant cancer models.

bioRxiv · Sep 16, 2025 · PreprintCancer Biology